Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: April 15, 2022
Event: Entry into a Material Definitive Agreement regarding the Company's Credit Agreement.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or specific debt balances. The document focuses exclusively on the terms of a credit facility amendment.
- Credit Facility Basket: The amendment provides for an unlimited cash and cash equivalent basket.
- Leverage Ratio Condition: The basket is measured against a leverage ratio net of cash globally in excess of $200 million.
Material Changes
On April 15, 2022, the Company entered into Amendment No. 2 to its Credit Agreement, originally dated April 15, 2019, and previously amended on November 15, 2021. The material changes include:
- Extension of certain reporting requirements.
- Establishment of an unlimited cash and cash equivalent basket subject to the leverage ratio condition noted above.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed beyond the standard qualification that the summary is subject to the complete terms of the Amendment filed as Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 (Amendment No. 2) for the complete terms of the credit agreement modification.
- Verify the Company's current global leverage ratio net of cash to confirm eligibility for the unlimited cash basket.
- Confirm the specific reporting requirements extended by the amendment.